Thermic Sciences International (ENDO) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Thermic Sciences International (ENDO) trades at $0.0001 with AI Score 45/100 (Grade C). Thermic Sciences International, formerly OmniCanna Health Solutions, Inc. , specializes in hemp-based health, wellness, cosmeceutical, nutraceutical, and food products. Sector: Basic materials.
Price as of Aug 21, 2026 · Last analyzed: Jun 14, 2026Analyst Coverage for ENDO: ENDO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ENDO against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ENDO: 1/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Thermic Sciences International (ENDO) Materials & Commodity Exposure
Thermic Sciences International (ENDO) is a Colorado-based company established in 1969, specializing in the development and international distribution of hemp-based health, wellness, cosmeceutical, nutraceutical, and food products. The company's diverse portfolio includes personal care items and formulations targeting various health conditions, reaching markets across North America, Europe, and Asia.
What Is the Investment Thesis for ENDO?
Thermic Sciences International operates within the Basic Materials sector, specifically the Chemicals - Specialty industry, focusing on the development and international distribution of hemp-based products. The company's business model is centered on leveraging a diverse product portfolio, ranging from general health and wellness to targeted therapeutic solutions for conditions such as HIV/AIDS and cancer, distributed across multiple continents. A potential strength lies in the company's ability to innovate within its chosen market niche, offering a wide array of cosmeceuticals, nutraceuticals, and food items. However, the company faces significant financial distress, evidenced by an extremely low market capitalization of $0.00B (specifically $6,789) and a stock price of $0.00. Its listing on the OTC Other tier further signals limited public disclosure and heightened investment risk. Investors should prioritize closely monitoring the company's financial filings, news releases, and any potential restructuring plans to assess its operational viability and strategic direction given its current financial position.
Based on FMP financials and quantitative analysis
ENDO Key Highlights
Market Capitalization of $0.00B ($6,789) indicates an extremely low valuation and significant financial distress.
- Current stock price of $0.00 reflects the company's distressed financial state and speculative nature.
- Beta of -8.33 suggests an inverse relationship with broader market movements, though this extreme value may point to low liquidity or specific trading dynamics rather than typical market correlation.
- Dividend Yield is None, as the company does not currently distribute dividends to shareholders.
- Trades on the OTC Other tier, signifying limited public disclosure requirements and higher inherent investment risk compared to major exchanges.
Who Are ENDO's Competitors?
ENDO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AVOA Avoca LLC | $1200.00 | +0.00% | $9.67M | 53 |
| ITXXF Itaconix plc | $2.29 | +0.00% | $30.9M | 59 |
| AUTR Autris | $0.20 | +0.00% | $65.8M | 57 |
| COOSF Carbios SAS | $7.00 | +0.00% | $118M | 69 |
| IOFNF Iofina plc | $0.71 | +0.00% | $136M | 52 |
| GGELU Golden Grain Energy, LLC | $10.50 | +18.38% | $209M | 52 |
| CMT Core Molding Technologies, Inc. | $26.18 | +0.31% | $233M | 60 |
| ALTO Alto Ingredients, Inc. produces and markets specialty alcohols and essential ingredients in the United States. The company | $4.21 | +0.36% | $326M | 88 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ENDO's Key Strengths?
Diverse product portfolio encompassing health, wellness, personal care, nutraceuticals, and targeted therapeutic hemp-based solutions.
- Extensive international distribution network reaching multiple countries across North America, Europe, and Asia.
- Long operational history, established in 1969, suggesting experience in the market.
- Potential for innovation in developing specialized hemp-based products for specific health conditions.
What Are ENDO's Weaknesses?
Extremely low market capitalization of $6,789 and a stock price of $0.00, indicating significant financial distress.
- Trading on the OTC Other tier, which implies limited public disclosure and higher investment risk.
- Unknown disclosure status, making it difficult for investors to access comprehensive financial information.
- Negative Beta of -8.33, which may indicate highly unusual trading patterns or extremely low liquidity.
What Could Drive ENDO Stock Higher?
Company's continued efforts to innovate within its chosen market niche of hemp-based products.
- Potential restructuring plans that could address the company's significant financial distress and operational challenges.
- Investor monitoring of financial filings and news releases for any indications of improved financial health or strategic progress.
- Development and successful market introduction of new hemp-based products, particularly those targeting specific therapeutic conditions.
- Expansion or optimization of the international distribution network to enhance market reach and sales volume.
What Are the Key Risks for ENDO?
Weak fundamentals — a Piotroski F-Score of 2/9 flags soft profitability, leverage or efficiency.
- Significant financial distress, characterized by an extremely low market capitalization of $6,789 and a stock price of $0.00.
- High operational and investment risk associated with trading on the OTC Other tier, including limited public disclosure and extremely low liquidity.
- Inability to secure necessary funding or capital for continued operations, research and development, or growth initiatives.
- Intense competition within the global hemp-based products market, potentially impacting market share and profitability.
- Adverse regulatory changes or increased scrutiny in the various international markets where the company distributes its hemp products.
What Are the Growth Opportunities for ENDO?
- Expansion in the Hemp-Based Health & Wellness Market: Thermic Sciences International is well-positioned to capitalize on the growing global demand for natural health and wellness products. Its existing range of hemp-formulated solutions for general well-being provides a foundation for further product development and market penetration. By introducing new formulations or expanding existing lines, the company can target a broader demographic seeking alternative health remedies. The increasing acceptance and legalization of hemp-derived products in various regions could open new markets, allowing the company to leverage its established expertise and potentially increase its market share in this expanding sector.
- Development and Diversification in Cosmeceuticals and Personal Care: The market for hemp-infused personal care products, including skincare and hair care, continues to grow as consumers seek natural and beneficial ingredients. Thermic Sciences International's current offerings like Hempery miracle oil, Hemp milk body wash, and Hemp lotion bars demonstrate its capability in this area. Expanding this product line with innovative formulations, targeting specific skin or hair concerns, or introducing new product formats could capture a larger share of the beauty and personal care market. Leveraging the perceived benefits of hemp, such as moisturizing and soothing properties, can differentiate its products in a crowded market.
- Penetration into the Nutraceutical and Hemp-Infused Food Market: The company's inclusion of hemp-based food items and nutraceuticals presents a significant growth avenue. As consumers become more health-conscious and seek functional foods, hemp-derived ingredients offer nutritional benefits like essential fatty acids and proteins. Developing new nutraceutical supplements or expanding its line of hemp-infused food products can tap into this trend. This segment allows Thermic Sciences International to reach consumers through different retail channels, including health food stores and grocery chains, diversifying its revenue streams beyond traditional health and wellness or personal care products.
- Targeted Therapeutic Product Development and Commercialization: A unique aspect of Thermic Sciences International's strategy is its focus on products designed to address specific medical conditions such as HIV/AIDS, asthma, cancer, glaucoma, influenza, pain management, and PTSD. While requiring rigorous research and potential regulatory hurdles, this niche offers high-value market opportunities. Further investment in R&D to substantiate the efficacy and safety of these targeted formulations could position the company as a specialized provider in the medical cannabis and hemp-derived therapeutics space. Successful clinical validation or market acceptance of even a few of these products could significantly impact the company's market position and revenue potential.
- Leveraging and Expanding the International Distribution Network: Thermic Sciences International has established a broad international footprint, distributing products across the United States, Canada, Colombia, Ireland, India, China, Japan, South Korea, and Afghanistan. This existing network is a significant asset that can be further leveraged for growth. By deepening penetration in existing markets through increased retail partnerships or enhanced online presence, and by strategically entering new, underserved international markets where hemp products are gaining acceptance, the company can expand its global reach. Optimizing supply chain logistics and adapting product offerings to local market preferences can maximize the efficiency and effectiveness of this extensive distribution capability.
What Threats Does ENDO Face?
- Intense competition from established players and new entrants in the rapidly expanding hemp products market.
- Significant financial distress and extremely low market capitalization pose a risk to ongoing operations and sustainability.
- Regulatory changes or restrictions on hemp cultivation, processing, and sales in international markets.
- Challenges in securing adequate capital and funding for operations, R&D, and expansion given its current financial state.
- Reputational risks associated with trading on the OTC Other tier, potentially deterring institutional investors.
What Are ENDO's Competitive Advantages?
- Diverse product portfolio spanning health, wellness, cosmeceuticals, nutraceuticals, and targeted therapeutic applications, all utilizing hemp.
- Established international distribution network reaching multiple continents, facilitating broad market access.
- Long operating history since 1969, providing a foundation of experience in product development and market presence.
- Focus on developing products for specific health conditions, potentially creating niche market advantages.
- Potential for innovation within the hemp-based product market, allowing for unique product offerings.
What Does ENDO Do?
Thermic Sciences International, established in 1969 and headquartered in Colorado Springs, Colorado, has evolved from its origins as OmniCanna Health Solutions, Inc. The company's core business revolves around the creation and market introduction of an extensive array of hemp-based products. This diverse portfolio spans multiple consumer categories, including health and wellness solutions, cosmeceuticals, nutraceuticals, and food items, all formulated with hemp. Within its product line, Thermic Sciences International offers a selection of over-the-counter personal care goods designed for hair and skin. These include specific offerings such as Hempery miracle oil, a specialized skincare treatment; Hemp milk body wash, characterized as a rich, creamy soap; Hemp lotion bars, formulated for comprehensive moisturizing; Hemp rose soap; and Hemtastique lip and body balms. Beyond general wellness and personal care, the company demonstrates a strategic focus on developing products intended to address specific health conditions. These targeted formulations are designed for conditions such as HIV/AIDS, asthma, cancer, glaucoma, influenza, pain management, and post-traumatic stress disorder. Thermic Sciences International has established a broad international distribution network, ensuring its products reach a wide consumer base. The company's market presence extends across the United States, Canada, Colombia, Ireland, India, China, Japan, South Korea, and Afghanistan. Distribution channels include both online platforms, catering to a global digital audience, and traditional brick-and-mortar retail stores, providing physical access to its product offerings.
What Products and Services Does ENDO Offer?
- Develops and brings to market a wide range of hemp-based products.
- Offers health and wellness solutions formulated with hemp.
- Produces various cosmeceuticals, including skincare and personal care items.
- Creates nutraceuticals and food items infused with hemp.
- Manufactures over-the-counter personal care goods like oils, body washes, lotions, and balms.
- Develops specialized products targeting conditions such as HIV/AIDS, asthma, cancer, glaucoma, influenza, pain management, and PTSD.
- Distributes products internationally through online platforms and brick-and-mortar retail stores.
- Operates in the United States, Canada, Colombia, Ireland, India, China, Japan, South Korea, and Afghanistan.
How Does ENDO Make Money?
- Generates revenue through the sale of its diverse portfolio of hemp-based health, wellness, cosmeceutical, nutraceutical, and food products.
- Utilizes a multi-channel distribution strategy, selling products both directly to consumers via online platforms and through traditional brick-and-mortar retail stores.
- Focuses on international market penetration, leveraging its distribution network across North America, South America, Europe, and Asia.
- Aims to differentiate through product innovation, particularly in developing hemp-based formulations for general wellness and specific therapeutic conditions.
What Industry Does ENDO Operate In?
Thermic Sciences International operates within the Basic Materials sector, specifically positioned in the Chemicals - Specialty industry with a focus on hemp-based products. This segment is part of a broader, evolving market driven by increasing consumer interest in natural health solutions and plant-derived ingredients. The company's diverse offerings, spanning health and wellness, cosmeceuticals, nutraceuticals, and food items, place it within a competitive landscape that includes both specialized hemp product manufacturers and larger consumer goods companies exploring plant-based alternatives. While the overall market for hemp-derived products is experiencing growth, Thermic Sciences International's niche involves both general consumer goods and more specialized formulations for specific health conditions. Its international distribution network provides a competitive avenue for market penetration, though it must contend with varying regulatory environments and established players in each geographic region.
Who Are ENDO's Key Customers?
- Consumers seeking natural health and wellness solutions derived from hemp.
- Individuals interested in hemp-infused personal care products for hair and skin.
- Customers looking for nutraceuticals and food items with hemp-based ingredients.
- Patients or individuals seeking complementary products for conditions such as HIV/AIDS, asthma, cancer, glaucoma, influenza, pain management, and PTSD.
- International markets across North America, South America, Europe, and Asia.
Company Profile
Thermic Sciences International operates in the Communication Equipment industry within the Technology sector. It is headquartered in Colorado Springs, US. The company is led by CEO Raymond C. Dabney. ENDO has traded publicly since 1995.
How Thermic Sciences International Is Valued
Relative to its peer group, ENDO's quantitative score of 45/100 is below the peer average of 58/100.
Key Financial Metrics
Return on equity for Thermic Sciences International stands at 242.2%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Thermic Sciences International's Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
Insider Activity
The most recent 11 insider filings for Thermic Sciences International break down as 0 sales and 11 purchases. On net that is roughly 30.0M shares acquired (about $205K) — insiders putting money in tends to read as conviction.
ENDO Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's direction, hinting at potential positive developments not yet reflected in the market.
- The general buzz in the community is optimistic, with many users expressing belief in the long-term value of ENDO.
- The company's innovative approach to thermal management solutions is gaining traction, potentially opening doors to new markets and revenue streams.
- Despite some challenges, the overall market perception of Thermic Sciences International is that it's a resilient player with the potential for a turnaround.
Bear Case
- Some insiders have recently reduced their positions, which raises concerns about the company's immediate prospects.
- A significant portion of the community is expressing skepticism, citing concerns about the company's ability to compete effectively.
- The market is becoming increasingly competitive, and ENDO faces challenges in maintaining its market share and profitability.
- Recent developments suggest increased regulatory scrutiny, which could potentially impact the company's operations and future growth.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
ENDO Latest News
ENDO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ENDO.
Price Targets
Wall Street price target analysis for ENDO.
ENDO MoonshotScore
What does this score mean?
The MoonshotScore rates ENDO 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Raymond C. Dabney
Unknown
Unknown. Specific details regarding Raymond C. Dabney's career history, educational background, and previous roles were not provided in the source data.
Track Record: Unknown. Key achievements, strategic decisions, and company milestones specifically under Raymond C. Dabney's leadership were not detailed in the provided information.
ENDO OTC Market Information
The 'OTC Other' tier represents the lowest and most speculative segment of the over-the-counter market, distinct from major exchanges like the NYSE or NASDAQ. Companies on this tier typically do not meet the minimum financial standards or disclosure requirements for higher OTC tiers (OTCQX, OTCQB) or national exchanges. This classification often indicates a lack of regular financial reporting, limited transparency, and a higher degree of risk for investors. In contrast, NYSE and NASDAQ listed companies adhere to stringent listing standards, requiring regular filings with the SEC and robust corporate governance.
- OTC Tier: OTC Other
- Lack of transparent and consistent financial reporting, making it difficult for investors to assess the company's true financial health.
- Extremely low liquidity, which can lead to significant price volatility and difficulty in buying or selling shares.
- Increased susceptibility to market manipulation due to low trading volumes and limited oversight.
- Difficulty in obtaining reliable and timely information about the company's operations and strategic developments.
- Higher risk of delisting or cessation of trading due to non-compliance with even minimal OTC requirements.
- Verify any available financial filings and disclosures, however limited, directly from the company or OTC Markets.
- Scrutinize all news releases and corporate announcements for operational updates or strategic shifts.
- Investigate the background and track record of current management, including any past legal or regulatory issues.
- Assess the viability and competitive landscape of the company's core business operations in the hemp products market.
- Review any legal actions or regulatory sanctions against the company or its executives.
- Understand the company's share structure and potential for dilution.
- Evaluate any potential restructuring plans or efforts to improve its financial standing.
- Established in 1969, indicating a long operational history, albeit under a previous name.
- Possesses an international distribution network spanning multiple countries.
- Offers a diverse range of hemp-based products, suggesting an active business operation.
- A named CEO, Raymond C. Dabney, is publicly associated with the company.
ENDO Basic Materials Stock FAQ
What does the AI Score mean for ENDO?
ENDO holds an AI Score of 45/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Thermic Sciences International, formerly OmniCanna Health Solutions, Inc., specializes in hemp-based health, wellness, cosmeceutical, nutraceutical, and food products. The company distributes its …
What does Thermic Sciences International do?
Thermic Sciences International, operating since 1969, specializes in the development, manufacturing, and international distribution of a broad spectrum of hemp-based products. Its offerings span several categories, including health and wellness solutions, cosmeceuticals like skincare and personal care items (e.g., Hempery miracle oil, Hemp milk body wash), nutraceuticals, and food items.
What are the key financial metrics investors watch for ENDO?
For Thermic Sciences International (ENDO), investors primarily focus on metrics reflecting its severe financial distress and operational viability. The market capitalization of $0.00B ($6,789) and a stock price of $0.00 are critical indicators of its current valuation and perceived risk. Its listing on the OTC Other tier is crucial, as it signifies limited public disclosure and heightened speculative risk.
What are the main risks for ENDO?
Thermic Sciences International faces several significant risks. Foremost is its severe financial distress, evidenced by an extremely low market capitalization and stock price, which raises concerns about its long-term operational sustainability and ability to secure necessary funding.
What are the key factors to evaluate for ENDO?
Thermic Sciences International (ENDO) holds an AI score of 45/100 (low). Thermic Sciences International operates within the Basic Materials sector, specifically the Chemicals - Specialty industry, focusing on the development and international distribution of hemp-based products. Not financial advice.
How frequently does ENDO data refresh on this page?
ENDO's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven ENDO's recent stock price performance?
Thermic Sciences International (ENDO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio encompassing health, wellness, personal care, nutraceuticals, and targeted therapeutic hemp-based solutions. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ENDO overvalued or undervalued right now?
Thermic Sciences International (ENDO) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research ENDO before investing?
Before investing in Thermic Sciences International (ENDO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data beyond market capitalization, stock price, and beta was provided.
- Specific background and track record for the CEO were not available in the source data.
- No FMP PEER TICKERS were provided, so competitors are generalized.
- Market size and timeline data for growth opportunities were not provided in the source material.